These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12409629)

  • 1. Effect of HMG-CoA reductase inhibitor on plasma cholesteryl ester transfer protein activity in primary hypercholesterolemia: comparison among CETP/TaqIB genotype subgroups.
    Kotake H; Sekikawa A; Tokita Y; Ishigaki Y; Oikawa S
    J Atheroscler Thromb; 2002; 9(5):207-12. PubMed ID: 12409629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes.
    van Venrooij FV; Stolk RP; Banga JD; Sijmonsma TP; van Tol A; Erkelens DW; Dallinga-Thie GM;
    Diabetes Care; 2003 Apr; 26(4):1216-23. PubMed ID: 12663600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.
    Carlquist JF; Muhlestein JB; Horne BD; Hart NI; Bair TL; Molhuizen HO; Anderson JL
    Am Heart J; 2003 Dec; 146(6):1007-14. PubMed ID: 14660992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men.
    Liu S; Schmitz C; Stampfer MJ; Sacks F; Hennekens CH; Lindpaintner K; Ridker PM
    Atherosclerosis; 2002 Apr; 161(2):469-74. PubMed ID: 11888533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS).
    Klerkx AH; de Grooth GJ; Zwinderman AH; Jukema JW; Kuivenhoven JA; Kastelein JJ
    Eur J Clin Invest; 2004 Jan; 34(1):21-8. PubMed ID: 14984434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.
    Brousseau ME; O'Connor JJ; Ordovas JM; Collins D; Otvos JD; Massov T; McNamara JR; Rubins HB; Robins SJ; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1148-54. PubMed ID: 12117730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An interaction between the TaqIB polymorphism of cholesterol ester transfer protein and smoking is associated with changes in plasma high-density lipoprotein cholesterol levels in Turks.
    Hodoğlugil U; Williamson DW; Huang Y; Mahley RW
    Clin Genet; 2005 Aug; 68(2):118-27. PubMed ID: 15996208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesteryl ester transfer protein TaqIB polymorphism and its relation to parameters of the insulin resistance syndrome in an Austrian cohort.
    Weitgasser R; Galvan G; Malaimare L; Derflinger I; Hedegger M; Lang J; Iglseder B; Ladurner G; Paulweber B
    Biomed Pharmacother; 2004 Dec; 58(10):619-27. PubMed ID: 15589073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes.
    Dullaart RP; Hoogenberg K; Riemens SC; Groener JE; van Tol A; Sluiter WJ; Stulp BK
    Diabetes; 1997 Dec; 46(12):2082-7. PubMed ID: 9392500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vitamin E and HMG-CoA reductase inhibition on cholesteryl ester transfer protein and lecithin-cholesterol acyltransferase in hypercholesterolemia.
    Napoli C; Leccese M; Palumbo G; de Nigris F; Chiariello P; Zuliani P; Somma P; Di Loreto M; De Matteis C; Cacciatore F; Abete P; Liguori A; Chiariello M; D'Armiento FP
    Coron Artery Dis; 1998; 9(5):257-64. PubMed ID: 9710685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the distribution and association of cholesteryl ester transfer protein-TaqIB polymorphism and plasma concentration in general population].
    Liu J; Zhao D; Liu S; Liu J; Qin LP; Wu ZS
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Apr; 24(4):300-3. PubMed ID: 12820950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study.
    Ordovas JM; Cupples LA; Corella D; Otvos JD; Osgood D; Martinez A; Lahoz C; Coltell O; Wilson PW; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1323-9. PubMed ID: 10807749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia.
    Mohrschladt MF; van der Sman-de Beer F; Hofman MK; van der Krabben M; Westendorp RG; Smelt AH
    Eur J Hum Genet; 2005 Jul; 13(7):877-82. PubMed ID: 15856070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.
    Boekholdt SM; Sacks FM; Jukema JW; Shepherd J; Freeman DJ; McMahon AD; Cambien F; Nicaud V; de Grooth GJ; Talmud PJ; Humphries SE; Miller GJ; Eiriksdottir G; Gudnason V; Kauma H; Kakko S; Savolainen MJ; Arca M; Montali A; Liu S; Lanz HJ; Zwinderman AH; Kuivenhoven JA; Kastelein JJ
    Circulation; 2005 Jan; 111(3):278-87. PubMed ID: 15655129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDL cholesterol and TaqIB cholesteryl ester transfer protein gene polymorphism in renal transplant recipients.
    Radeau T; Vohl MC; Houde I; Lachance JG; Noël R; Després JP; Douville P; Bergeron J
    Nephron; 2000 Apr; 84(4):333-41. PubMed ID: 10754410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of cholesteryl ester transfer protein activity and TaqIB polymorphism with lipoprotein variations in Japanese subjects.
    Ikewaki K; Mabuchi H; Teramoto T; Yamada N; Oikawa S; Sasaki J; Takata K; Saito Y;
    Metabolism; 2003 Dec; 52(12):1564-70. PubMed ID: 14669156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of APOE, CETP, and PCSK9 polymorphisms on simvastatin response in Thai hypercholesterolemic patients.
    Wanmasae S; Sirintronsopon W; Porntadavity S; Jeenduang N
    Cardiovasc Ther; 2017 Dec; 35(6):. PubMed ID: 28851085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group.
    Kuivenhoven JA; Jukema JW; Zwinderman AH; de Knijff P; McPherson R; Bruschke AV; Lie KI; Kastelein JJ
    N Engl J Med; 1998 Jan; 338(2):86-93. PubMed ID: 9420339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma cholesteryl ester transfer protein concentrations predict cardiovascular events in patients with coronary artery disease treated with pravastatin.
    Marschang P; Sandhofer A; Ritsch A; Fiŝer I; Kvas E; Patsch JR
    J Intern Med; 2006 Aug; 260(2):151-9. PubMed ID: 16882279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: a study based on coronary angiography.
    Goto A; Sasai K; Suzuki S; Fukutomi T; Ito S; Matsushita T; Okamoto M; Suzuki T; Itoh M; Okumura-Noji K; Yokoyama S
    Atherosclerosis; 2001 Nov; 159(1):153-63. PubMed ID: 11689217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.